News

Charity makes cancer gene freely available across Europe

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7437.423 (Published 19 February 2004) Cite this as: BMJ 2004;328:423
  1. Susan Mayor
  1. London

    The charity Cancer Research UK announced last week that it had obtained a Europe-wide patent onthe hereditary breast cancer gene BRCA2 and will allow publicly owned laboratories and hospitals to use the gene free of charge.

    The granting of the European patent will extend access to the gene. Currently access is available to UK researchers because the charity already holds a UK patent on the gene.

    The patent covers all attempts to sequence the gene or to test for damaged or inactive variants—such as testing people for BRCA2 variants to assess their risk of …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe